Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani MT, Fabris F, Zver S, Réti M, Mikovic D, Karimi M, Giuffrida G, Laurenti L, Mannucci PM. Peyvandi F, et al. Among authors: mikovic d. Haematologica. 2008 Feb;93(2):232-9. doi: 10.3324/haematol.11739. Epub 2008 Jan 26. Haematologica. 2008. PMID: 18223285 Free article.
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura.
Mancini I, Ricaño-Ponce I, Pappalardo E, Cairo A, Gorski MM, Casoli G, Ferrari B, Alberti M, Mikovic D, Noris M, Wijmenga C, Peyvandi F; Italian Group of TTP Investigators. Mancini I, et al. Among authors: mikovic d. J Thromb Haemost. 2016 Dec;14(12):2356-2367. doi: 10.1111/jth.13548. Epub 2016 Dec 3. J Thromb Haemost. 2016. PMID: 27762046 Free article.
Diagnostic relevance of ADAMTS13 activity: evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosis.
Vucelić D, Miković D, Rajić Z, Savić N, Budisin Z, Antonijević NM, Obradović S, Jevtić D, Palla R, Valsecchio C, Peyvandi F. Vucelić D, et al. Among authors: mikovic d. Srp Arh Celok Lek. 2013 Jul-Aug;141(7-8):466-74. doi: 10.2298/sarh1308466v. Srp Arh Celok Lek. 2013. PMID: 24073552 Free article.
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.
Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, Pergantou H, Platokouki H, Giangrande P, Peerlinck K, Celkan T, Ozdemir N, Bidlingmaier C, Ingerslev J, Giansily-Blaizot M, Schved JF, Gilmore R, Gadisseur A, Benedik-Dolničar M, Kitanovski L, Mikovic D, Musallam KM, Rosendaal FR; European Network of Rare Bleeding Disorders Group. Peyvandi F, et al. Among authors: mikovic d. J Thromb Haemost. 2012 Apr;10(4):615-21. doi: 10.1111/j.1538-7836.2012.04653.x. J Thromb Haemost. 2012. PMID: 22321862 Free article.
Central nervous system bleeding in patients with rare bleeding disorders.
Siboni SM, Zanon E, Sottilotta G, Consonni D, Castaman G, Mikovic D, Biondo F, Tagliaferri A, Iorio A, Mannucci PM, Peyvandi F. Siboni SM, et al. Among authors: mikovic d. Haemophilia. 2012 Jan;18(1):34-8. doi: 10.1111/j.1365-2516.2011.02545.x. Epub 2011 May 4. Haemophilia. 2012. PMID: 21539694
38 results